Drug intelligence / Profile preview

Eurotium amstelodami

Development stage
Preclinical
Lead developer
Greer Laboratories
Modality
Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Intradermal, Percutaneous, Subcutaneous
01

Overview

*Eurotium amstelodami* is a xerophilic fungus traditionally recognized as a common spoilage organism in low-moisture foods and animal feeds. In a biomedical context, it is identified as one of the primary etiological agents of Farmer's Lung Disease (FLD), a form of hypersensitivity pneumonitis; consequently, its purified and recombinant antigens are utilized in standardized serological diagnostic ELISA tests. Recent preclinical research has explored its potential as a probiotic fungus, demonstrating protective effects against dextran sulfate sodium (DSS)-induced ulcerative colitis and gut-derived liver injury in murine models. The proposed mechanism involves the modulation of gut microbial community structure, restoration of bile acid metabolism via the farnesoid X receptor (FXR) and G protein-coupled bile acid receptor 1 (TGR5), and the suppression of inflammatory pathways including TLR4/NF-kB and the NLRP3 inflammasome. Additionally, *E. amstelodami* is utilized in the fermentation of specialty teas (such as Fuzhuan brick tea) and high-temperature Daqu, where it facilitates the bioconversion of flavonoid glycosides into bioactive aglycones and produces secondary metabolites like asperflavin with anti-inflammatory properties.

Other names
Aspergillus amstelodami
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Eurotium amstelodami.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eurotium amstelodami.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call